Premier Insight
Diagnostics

Premier Insight 280: Engineering a PMA Study

Background

Colorectal cancer (CRC) is the second most deadly form of cancer – although it is among the most curable and the easiest to detect in its early stages. The reason: patients notoriously avoid colonoscopy, placing themselves at unnecessary risk. Our client developed a unique solution – a multi-target, noninvasive screening test that could be facilitated by patients in their homes. They came to Premier Research to conduct the pre-market approval (PMA) study.